Hsp90 inhibitors reduce influenza virus replication in cell culture

Virology. 2008 Aug 1;377(2):431-9. doi: 10.1016/j.virol.2008.04.040.

Abstract

The viral RNA polymerase complex of influenza A virus consists of three subunits PB1, PB2 and PA. Recently, the cellular chaperone Hsp90 was shown to play a role in nuclear import and assembly of the trimeric polymerase complex by binding to PB1 and PB2. Here we show that Hsp90 inhibitors, geldanamycin or its derivative 17-AAG, delay the growth of influenza virus in cell culture resulting in a 1-2 log reduction in viral titre early in infection. We suggest that this is caused by the reduced half-life of PB1 and PB2 and inhibition of nuclear import of PB1 and PA which lead to reduction in viral RNP assembly. Hsp90 inhibitors may represent a new class of antiviral compounds against influenza viruses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzoquinones / pharmacology*
  • Cell Culture Techniques
  • HSP90 Heat-Shock Proteins / antagonists & inhibitors*
  • HSP90 Heat-Shock Proteins / metabolism
  • Humans
  • Influenza A virus / drug effects*
  • Influenza A virus / enzymology
  • Influenza A virus / physiology
  • Lactams, Macrocyclic / pharmacology*
  • RNA-Dependent RNA Polymerase / metabolism*
  • Viral Proteins / metabolism*
  • Virus Assembly
  • Virus Replication / drug effects*

Substances

  • Benzoquinones
  • HSP90 Heat-Shock Proteins
  • Lactams, Macrocyclic
  • PB2 protein, Influenzavirus A
  • Viral Proteins
  • influenza virus polymerase basic protein 1
  • RNA-Dependent RNA Polymerase
  • geldanamycin